Report Highlights
The global market for renal disease treatments was valued at $60.8 billion in 2025, and it is estimated to increase from $65.7 billion in 2026 to reach $99.8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 through 2031.
Report Includes
- 172 data tables and 52 additional tables
- Analysis of the global renal disease treatments market, including current market size and future growth potential
- Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
- Detailed segmentation of the market by product type, disease type, treatment, end user, and region
- Analysis of key market drivers, restraints, and opportunities influencing market growth
- Insights into industry trends, emerging technologies, and pipeline developments
- Evaluation of the regulatory landscape across major regions
- Analysis of regional markets, including North America, Europe, Asia-Pacific, the Middle East & Africa, and South America
- Competitive landscape analysis, including market share and strategic developments of key players
- Profiles of leading and emerging companies, including Fresenius Medical Care AG, Vantive, AstraZeneca, Johnson & Johnson, and NIPRO, covering their product portfolios, financials, and recent developments
Report Scope
The global market for renal disease treatments is segmented by product type, disease type, treatment, and end user. The product type is further divided into devices, consumables, and biologics and drugs. The devices segment scope includes hemodialysis machines, dialysis systems, peritoneal dialysis systems, automated peritoneal dialysis systems, dialysis chairs, reprocessing systems, and filtration systems. Biologics and drugs encompass conventional drug treatments and advanced drug delivery systems, all designed to slow disease progression and enhance patient outcomes. Consumables such as dialyzers, catheters, dialysis kits, concentrates, and bicarbonate are used in renal disease management.
By treatment, the market is segmented into dialysis, transplantation, and other treatments, which include continuous renal replacement therapy (CRRT), conservative management, and wearable dialysis devices. The dialysis segment is further divided into hemodialysis and peritoneal dialysis. Based on end user, the market is classified into hospitals and clinics, home care settings, and other end users (dialysis centers and research institutions). While hospitals and clinics account for the largest share due to comprehensive care capabilities, the home care segment is experiencing rapid growth driven by increased patient preference, convenience, and advances in dialysis technologies. For market estimates, data has been provided for 2025 as the base year, 2026 as the estimated year, and forecasted for 2026 through 2031.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2025 | ||||||||||||||||
| Forecast period considered | 2026-2031 | ||||||||||||||||
| Base year market size | $60.8 Billion | ||||||||||||||||
| Market size forecast | $99.8 Billion | ||||||||||||||||
| Growth rate | CAGR of 8.7% for the forecast period of 2026-2031 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Product Type, Disease type, Treatment, End User, Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, and Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Belgium, the Netherlands, Sweden, Russia, China, Japan, India, Australia, New Zealand, Singapore, Malaysia, Thailand, Indonesia, Brazil, Argentina, Chile, Colombia, Peru, Venezuela, Paraguay | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Progression from ESRD to CKD
- Growing prevalence of Chronic Diseases
- Increasing Number of Dialysis Centers
- Key challenges include- High Cost of Treatment and Limited Reimbursement, Stringent Regulatory and Approval Requirement
- Key opportunities include- Growing Investment in Regenerative Medicine and Biologic Therapies, Focus on Home Dialysis Systems
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Chronic Kidney Disease: Global Markets and Technologies
The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Renal Dialysis Equipment: Technologies and Global Markets
The global market for renal dialysis equipment is estimated to increase from $17.8 billion in 2022 to reach $23.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.8% from 2022 through 2027.
Renal Biomarkers: Technologies and Global Markets
The global market for renal biomarkers is estimated to increase from $1.2 billion in 2022 to reach $1.7 billion by 2027, at a compound annual growth rate (CAGR) of 7.6% from 2022 through 2027.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Renal Disease Treatments: Products and Therapies
The global market for renal disease treatments was valued at $60.8 billion in 2025, and it is estimated to increase from $65.7 billion in 2026 to reach $99.8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 through 2031.
State of the Life Sciences Industry - 2026 Third Quarter Review
Review Q3 2026 life sciences trends, including market shifts, emerging technologies, industry activity and the sector outlook.
Latest Development, Product Innovations, and Treatments for Diabetes
The global market for latest developments, product innovations, and treatments for diabetes was valued at $144.5 billion in 2025 and is estimated to increase from $162.2 billion in 2026 to reach $295 billion by the end of 2031, at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2031.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.
Liquid Biopsy with Emphasis on Cancer: Global Markets
The global market for liquid biopsy with emphasis on cancer is expected to grow from $4.1 billion in 2026 and is projected to reach $8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 14.1% during the forecast period of 2026 to 2031.
Top Trending Reports
Agricultural Biotechnology: Emerging Technologies and Global Markets
The global agricultural biotechnology market was valued at an estimated $84.7 billion in 2025 and is estimated to increase from $91.5 billion in 2026 to reach $137 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2031.
State of the Life Sciences Industry - 2026 Third Quarter Review
Review Q3 2026 life sciences trends, including market shifts, emerging technologies, industry activity and the sector outlook.
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
State of the Energy & Sustainability Industry - 2026 Third Quarter Review
Explore the Q3 2026 Energy & Sustainability industry review, covering key market trends, emerging technologies, industry developments and outlook.
Generative AI: Global Markets
The global market for generative AI is expected to grow from $138.2 billion in 2026 and is projected to reach $680.5 billion by the end of 2031, at a compound annual growth rate (CAGR) of 37.6% during the forecast period of 2026 to 2031.
Report Highlights
The U.S. market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021.
Report Includes
- An in-depth analysis of the market for kidney failure treatment products and services, forecasting growth and trends in various sectors.
- Analyses of market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Detailed coverage of products and services including those for treating acute renal failure, chronic renal failure, and end-stage renal disease, the final phase of chronic kidney failure.
- Specfic segmentation of the market into pharmaceuticals used to address the conditions associated with kidney failure (i.e., hypertension, diabetes, and anemia); hemodialysis and peritoneal dialysis products and services; and surgical procedures used to keep the end-stage kidney patient alive (i.e., surgeries to create vascular access sites for dialysis, and kidney transplantation).
- Evaluation of the industry structure and dynamics, as well as technological developments.
- Profiles of major players in the industry.
Report Highlights
- Overall sales in the global market for renal failure treatmentwere worth nearly $28 billion in 2009, it is estimated to increase to $33.5 billion at a 5 year compound annual growth rate (CAGR) of 3.7%.
- The largest segment CKD treatment products and therapies (including dialysis consumables) market was nearly $26.5 billion in 2009. This is expected to rise to $31.7 billion in 2014, at a CAGR of 3.6%.
- ARF treatment products and therapies (including dialysis consumables) market reached $955 million in 2009 and is projected to reach $1.4 billion in 2014, at a CAGR of 8.7%.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More